Approach to the poisoned patient

Disease-a-Month

Volumn 42, Issue 9, 1996, Pages 514-607

  Krenzelok, Edward P ^a   Leikin, Jerrold B ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANTIDOTE; GLUCOSE; IPECAC; NALOXONE; OXYGEN; THIAMINE;

ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; HEMODIALYSIS; HEMOPERFUSION; HUMAN; INTOXICATION; IRON OVERLOAD; LAVAGE; LEAD POISONING; OXYGEN THERAPY; PATIENT CARE; REVIEW; TREATMENT PLANNING;

HUMANS; POISONING;

EID: 0030239141     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-5029(96)90001-2     Document Type: Review

References (150)

1. DeVenenis of Petrus Abbonus
2. What is there that is not a poison: a study of the third defense by Paracelsus
3. 1994 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
4. 1993 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
5. 1983 Annual Report of the American Association of Poison Control Centers National Data Collection System
6. 1984 Annual Report of the American Association of Poison Control Centers National Data Collection System
7. 1985 Annual Report of the American Association of Poison Control Centers National Data Collection System
8. 1986 Annual Report of the American Association of Poison Control Centers National Data Collection System
9. 1987 Annual Report of the American Association of Poison Control Centers National Data Collection System
10. 1988 Annual Report of the American Association of Poison Control Centers National Data Collection System
11. 1989 Annual Report of the American Association of Poison Control Centers National Data Collection System
12. 1990 Annual Report of the American Association of Poison Control Centers National Data Collection System
13. 1991 Annual Report of the American Association of Poison Control Centers National Data Collection System
14. 1992 Annual Report of the American Association of Poison Control Centers National Data Collection System
15. Acute iron poisoning
16. Unintentional carbon monoxide-related deaths in the United States, 1979 through 1988
17. The poisoned patient with altered consciousness: controversies in the use of a “coma cocktail”
18. Toxidrome recognition to improve efficiency of emergency urine drug screens
19. The unknown poison
20. Clinical features and management of intoxication due to hallucinogenic drugs
21. Ping-pong gaze associated with monoamine oxidase inhibitor overdose
22. Radiopacity study of extended-release formulations using digitalized radiography
23. Hydrofluoric acid
24. Sodium and potassium
25. A fast-acting oral liquid emetic agent
26. Emergency induction of emesis using liquid detergent products: a report of 15 cases
27. Use of liquid dishwashing detergent as an emetic in the outpatient management of poisoning: an update
28. Effect of milk on ipecac-induced emesis
29. Risk assessment of ipecac at home
30. In defense of retaining ipecac syrup as an over-the-counter drug
31. Non emetic effects of ipecac syrup
32. Pneumomediastinum and retropneumoperitoneum: an unusual complication of syrup of ipecac-induced emesis
33. Syrup of ipecac associated fatality: a case report
34. Ipecac use in the elderly: the unanswered question
35. Gastric rupture and death caused by ipecac syrup
36. Recurrent infantile vomiting due to intentional ipecac poisoning
37. Intentional ipecac poisoning: Munchausen syndrome by proxy
38. Intentional ipecac poisoning in children
39. Death due to chronic syrup of ipecac use in a patient with bulimia
40. A case of abuse of syrup of ipecac resulting in death
41. Death from ipecac intoxication in a patient with anorexia nervosa
42. Death resulting from ipecac syrup poisoning
43. Ipecac myopathy and cardiomyopathy
44. Emetine myopathy: two case reports with pathobiochemical analysis
45. Ipecac-induced myopathy simulating dermatomyositis
46. Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population
47. Efficacy of ipecac-induced emesis, orogastric lavage and activated charcoal for acute drug overdose
48. The knee-chest position does not improve efficacy of ipecac-induced emesis
49. Efficacy of syrup of ipecac-induced emesis for emptying gastric contents
50. Evaluation of gastric emptying using radionuclides: gastric lavage versus ipecac-induced emesis
51. Gastric emptying procedures in the selfpoisoned patient: are we forcing gastric content beyond the pylorus?
52. Ipecac-induced emesis and reduction of plasma concentrations of drugs following accidental overdose in children
53. The role of gastric lavage in the treatment of patients suffering from barbiturate overdose
54. Gastric aspiration and ravage in acute poisoning
55. Esophageal perforation: an unusual complication of gastric lavage
56. Charcoal-containing empyema complicating treatment for overdose
57. Management of acutely poisoned patients without gastric emptying
58. Esophageal tear following forceful removal of an impacted oral-gastric ravage tube
59. Efficacy of gastric emptying: gastric lavage versus emesis induced with ipecac
60. Efficacy of ipecac-induced emesis versus gastric lavage: a controlled study in normal adults
61. Interpreting gastric emptying studies
62. Container residue after the administration of aqueous activated charcoal products
63. Acceleration of body clearance of phenobarbital by oral activated charcoal
64. Effects of size and frequency of oral doses of charcoal on theophylline clearance
65. Gastrointestinal clearance of drugs with activated charcoal
66. Oral activated charcoal in the treatment of intoxications: role of single and repeated doses
67. The comparative efficacy of various multiple-dose activated charcoal regimens
68. Multiple-dose activated charcoal: a review of relevant clinical studies
69. Multiple-dose charcoal and enhancement of systemic drug clearance: summary of studies in animals and human volunteers
70. Activated charcoal dosing and the prevalence and predictors of emesis
71. Activated charcoal/sorbitol preparations: incidence of adverse effects
72. Charcoal aspiration: bronchiolitis obliterans after aspiration of activated charcoal
73. A fatality resulting multiple dose activated charcoal therapy
74. Aspiration of activated charcoal
75. Death complicating gastrointestinal decontamination: time to rethink “routine therapy”?
76. Preserving the emetic effect of syrup of ipecac with concurrent activated charcoal administration: a preliminary report
77. A prospective evaluation of the effect of activated charcoal before oral n-acetylcysteine therapy in acetaminophen overdose
78. Are activated charcoal-n-acetylcysteine interactions of clinical significance?
79. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption
80. Hypernatremia due to repeated doses of activated charcoal-sorbitol
81. Severe hypernatremic dehydration after use of an activated charcoal sorbitol suspension
82. Magnesium toxicity secondary to catharsis during management of theophylline poisoning
83. Hypermagnesemia: a potential complication during treatment of theophylline intoxication with oral activated charcoal and magnesiumcontaining cathartics
84. Dosage recommendations for activated charcoal-sorbitol treatment
85. Gastrointestinal transit times of a charcoal/sorbitol slurry in overdose patients
86. Whole bowel irrigation as a gastrointestinal decontamination procedure after acute poisoning
87. Efficiency of whole bowel irrigation with and without metoclopramide pretreatment
88. Acid and alkaline diuresis: when are they of value in the treatment of poisoning?
89. Extracorporeal removal of drugs and poisons by hemodialysis and hemoperfusion
90. Treatment of severe parathion intoxication
91. Predicting the clinical course in intentional drug overdose: implications for use of the intensive care unit
92. Role of the intensive care unit in the management of the poisoned patient
93. Admission criteria for tricyclic antidepressant ingestion
94. Extracorporeal membrane oxygenation
95. Extracorporeal membrane oxygenation support for cardiac dysfunction from tricyclic antidepressant overdose
96. Advances in the critical care of poisoned pediatric patients
97. An evaluation of cocaine-induced chest pain
98. Is admission after intravenous heroin overdose necessary?
99. Toxic inhalations
100. Acetaminophen poisoning
101. Acetaminophen overdose in children and adolescents
102. Efficacy of oral n-acetylcysteine in the treatment of acetaminophen overdose: analysis of a national multicenter study
103. Overdose of extended-release acetaminophen
104. late rise APAP level after overdose
105. Pharmacokinetics of extended relief (ER) vs. regular release (RR) Tylenol (APAP) in a simulated human overdose model
106. A pharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs. regular Tylenol)
107. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine
108. Intravenous acetylcysteine in paracetamolinduced fulminant hepatic failure
109. Acute and chronic effects of aspirin toxicity and their treatment
110. Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication
111. Ibuprofen overdose: 126 cases
112. Metabolic acidosis following ibuprofen overdose
113. Calcium channel blocker overdose
114. Calcium gluconate in severe verapamil intoxication
115. Amrinone as an antidote in experimental Verapamil overdose
116. Glucagon and phenylephrine combination vs glucagon alone in experimental verapamil overdose
117. Perfusion salad: making sense of verapamil overdose
118. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine
119. Verapamil toxicity-treatment with hemoperfusion
120. Lithium toxicity associated with a trichobezoar
121. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers
122. Effect of delayed treatment with sodium polystyrene sulfonate on serum lithium concentrations in mice
123. Comparison between acetate and bicarbonate dialysis for the treatment of lithium intoxication
124. Methanol half-life during ethanol administration: implications for management of methanol poisoning
125. Effects of 4-methylpyrazole: methanol/ethylene glycol antidote in healthy humans
126. Hypokalemia, hyperglycemia and plasma catecholamine activity after severe theophylline intoxication
127. Evaluation of theophylline overdoses and toxicities
128. Exchange transfusion in the treatment of severe theophylline poisoning
129. Reversal of tricyclic antidepressant induced cardiac conduction abnormalities by phenytoin
130. Cyclic antidepressant overdose: a review of current management strategies
131. Successful treatment of amoxapine-induced refractory status epilepticus with propofol (Diprivan)
132. Reduction of desipramine cardiotoxicity and prolongation of survival in rats with the use of polyclonal drug-specific antibody Fab fragments
133. Recombinant drug-specific single chain antibody Fv fragment redistributes 3H-desipramine in rats
134. Unintentional carbon monoxide-related deaths in the United States, 1979 through 1988
135. Predictors of occult carbon monoxide poisoning in patients with headache and dizziness
136. Occult carbon monoxide poisoning: validation of a prediction model
137. Carbon monoxide poisoning among recreational boaters
138. Carbon monoxide poisonings associated with snowobstructed vehicle exhaust systems: Philadelphia and New York City, January 1996
139. Relationship between venous and arterial carboxyhemoglobin levels in patients with suspected carbon monoxide poisoning
140. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen
141. Smoke inhalation among firefighters
142. Carbon monoxide: the silent killer with an audible solution
143. In-home CO dectectors: suburban Chicago experience
144. Exploring the facts on the odorless killer: carbon monoxide and the carbon monoxide detector ordinance-why the debate
145. Carbon monoxide detectors and emergency physicians